Effects of Pericapsular Nerve Group Block Applied in Patients Undergoing Hip Fracture Surgery.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-85
SponsorUmraniye Education and Research Hospital
About this trial
In this study, it was aimed to compare the multimodal analgesia application or the pericapsular nerve group (PENG) block methods in patients undergoing hip surgery. The effectiveness and benefit rate of the PENG block in postoperative pain will be evaluated.
Postoperative pain, need for additional analgesia, range of motion of the hip joint, mobilization time, length of hospital time and adverse events in patients undergoing hip fracture surgery with and without PENG block will be investigated.
Eligibility criteria
Qualifiers
Patients who will undergo hip fracture surgery Women and men aged 30-85
Disqualifiers
Patients under 30 years old, over 85 years old
American Society of Anesthesiology (ASA) IV,
Those with cognitive impairment (alzheimer, dementia, delirium, etc.)
Those with application site infection
Trial design
Treatments tested in this trial
- Pericapsular Nerve Group (PENG) Block
Treatment groups
70 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov